Statistical performance review on diagnosis of leukemia, glaucoma and diabetes mellitus using AI
The growth of artificial intelligence (AI) in the healthcare industry tremendously increases the patient outcomes by reshaping the way we diagnose, treat and monitor patients. AI‐based innovation in healthcare include exploration of drugs, personalized medicine, clinical diagnosis investigations, ro...
Gespeichert in:
Veröffentlicht in: | Statistics in medicine 2024-03, Vol.43 (6), p.1227-1237 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The growth of artificial intelligence (AI) in the healthcare industry tremendously increases the patient outcomes by reshaping the way we diagnose, treat and monitor patients. AI‐based innovation in healthcare include exploration of drugs, personalized medicine, clinical diagnosis investigations, robotic‐assisted surgery, verified prescriptions, pregnancy care for women, radiology, and reviewed patient information analytics. However, prediction of AI‐based solutions are depends mainly on the implementation of statistical algorithms and input data set. In this article, statistical performance review on various algorithms, Accuracy, Precision, Recall and F1‐Score used to predict the diagnosis of leukemia, glaucoma, and diabetes mellitus is presented. Review on statistical algorithms' performance, used for individual disease diagnosis gives a complete picture of various research efforts during the last two decades. At the end of statistical review on each disease diagnosis, we have discussed our inferences that will give future directions for the new researchers on selection of AI statistical algorithm as well as the input data set. |
---|---|
ISSN: | 0277-6715 1097-0258 |
DOI: | 10.1002/sim.10004 |